”The Company anticiapates results from the initial non-clinical animal study to be released in Feb 2019”.
”Overall, this work supports the plan to release the first clinical Plexaris drug product to a study site. Managing Exomeres to to a first in human small scale clinical study of Autologous Plexaris product for wound healing. This is currently planned for commencement CY 2019”. Around mid year I believe & we will have some results this month, pre-clinical. This is going to be great if trials successful. GLTAH
EX1 Price at posting:
61.0¢ Sentiment: Buy Disclosure: Held
